 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
- N4 p3 ~/ A- d# \. d; Q' M , S. ]! a6 y4 J; U# I& c
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX. n! E# W8 v% c) l
: M- ]( W7 r- M' g3 B2 wBY THE EDMONTON JOURNAL FEBRUARY 16, 2007/ x& L+ d( h$ z1 l
) q! l% \) [5 @5 S. a9 D5 l
# L( d( h. Y. |- \. S4 O/ r" _
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.* o6 M- p& y# Q) d
7 b( s* q- N& C& r
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM.". g& f7 \. r$ v3 {6 D
) D8 w# ~7 V' }6 H, i
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
6 E1 K1 G6 u' M1 c9 n6 `% \1 x, t, a5 ^2 v/ q& t' \
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.3 Q8 u5 q' I. l0 I' x: y* }
8 @& s3 c8 I- P0 m9 aIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
* {! R7 O, U! Q+ l, ?& w- p( D' Y: W. p+ G% r9 D
"As a scientist, it's one of the highlights of my CAREER," Shan said.) l$ |+ r5 |+ f0 h. @
4 X% s# S1 @8 o; B/ L
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."" c1 X5 u( K! S9 _$ u! k* `
* F& Q7 \( n+ Q- ]- a9 M$ ?# h* @
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
, U$ c# O3 h1 o# F1 J- U/ D
0 ?5 c, H6 O1 o, _* ]Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
6 e3 N2 r/ v7 ^% M D" i3 `# d
& Q+ g. _& C2 P+ q. o. o6 BThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
, Q% x" T- J" o: Z# V) R' c; A9 P9 l$ E" [3 Z- c
0 I. |2 }' [2 r7 ~) [6 C- U
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
$ b% A- v3 s4 [, y3 I4 b0 k
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
5 G( v) h$ F7 u q7 ~+ M
发表于 2015-2-28 19:45
